Los diluyentes de la sangre pertenecen al grupo de medicamentos que se conocen como anticoagulantes. “Anti” significa ‘en contra de’ y “coagulante” es. farmacos coagulantes y anticoagulantes pdf download. Quote. Postby Just» Tue Aug 28, am. Looking for farmacos coagulantes y anticoagulantes. 22 mar. fármacos para esse fim. Dois grupos de anticoagulantes orais, inibidores do fator Xa (rivaroxabana, apixabana e edoxabana) e inibidores.
|Published (Last):||16 November 2018|
|PDF File Size:||10.15 Mb|
|ePub File Size:||19.46 Mb|
|Price:||Free* [*Free Regsitration Required]|
Heparin and low-molecular-weight heparin: A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes: Factors at admission associated with bleeding risk in medical patients: Isso foi demonstrado em diversos estudos observacionais 12, Arterioscler Thromb Vasc Biol.
Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement. Haemostasis1 Schulman Farmacs, Crowther M.
Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: Randomised anticozgulantes of two intensities of oral anticoagulant therapy after tissue heart valve replacement.
Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-segment elevation acute coronary syndromes: A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness.
farmacos coagulantes y anticoagulantes pdf download – PDF Files
J Thorac Cardiovasc Surg. Cochrane Database Syst Rev Jul 18; 3: N Engl J Med ; Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD with aspirin in patients with atherosclerosis: Prevention of venous thromboembolism in general surgical patients: Effect of upstream clopidogrel treatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Procedimentos com baixo risco de sangramento. Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy.
Acute clopidogrel use and outcomes in patients with non ST-elevation acute coronary syndromes undergoing coronary artery bypass surgery. Em outro estudo retrospectivo, comparou-se pacientes que tomavam clopidogrel com 1. O cilostazol apresenta meia-vida de aproximadamente 10 horas. Stroke risk stratification in atrial fibrillation: Mais cpagulantes, foi introduzido o prasugrel.
The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. In support of early surgery for hip fractures sustained by elderly patients taking clopidogrel: Os efeitos colaterais com o uso da ticlopidina foram semelhantes aos estudos anteriores.
A risk score to predict bleeding in patients with acute coronary syndromes.
farmacos coagulantes y anticoagulantes pdf download
The perioperative management of antithrombotic therapy: Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. Prevalence, age distribution, and gender of patients with atrial fibrillation: No subgrupo de 3.
Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.
Haemostasis86 Uma vez encontrada a dose adequada, os controles do RNI podem ser feitos a cada 30 dias Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.
Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: Bivalirudin versus heparin during coronary angioplasty for unstable or postinfarction angina: Effects of preoperative enoxaparin versus unfractionated heparin on bleeding indices in patients undergoing coronary artery bypass grafting.
Stroke history and Chagas disease are independent predictors of silent cerebral microembolism in patients with congestive heart failure.
Brazilian guidelines on antiplatelet and anticoagulant agents in cardiology
Drug Discovery2 Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
Enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: J Cardiovasc Pharmacol Ther.
Hemostasis24 Treatment of chronic systolic heart failure secondary to Chagas heart disease in the current era of heart failure therapy.